
FulcrumSec claims it stole 1.3TB from Novo Nordisk, demanded $25M on Monday
Novo Nordisk says it did not pay, leaving FulcrumSec to decide what comes next with the alleged data.

Curating from trusted global sources…
Curated from trusted global sources, refined into briefing-grade analysis with executive summaries, insights, and bullet-point takeaways.

Novo Nordisk says it did not pay, leaving FulcrumSec to decide what comes next with the alleged data.

BMW cuts its outlook, spooking European markets and forcing executives to reassess China exposure and scenario planning.

Mynt, the owner of GCash, has moved toward a public listing, reshaping how investors and regulators view PH fintech growth.

A $1.2 billion Pizza Hut acquisition by Yum China triggered a cooler-than-expected market reaction, signaling risks boards should underwrite.

Beijing signals support for five-year yuan-denominated futures, aiming to make long-term yuan investing easier offshore.

Inside Lidl’s pivot from supermarket aisles to beer taps, and why it matters for retail strategy and regulation.

Justice argues the lawsuit threatens national, economic, and energy security. The NAACP says it is a power grab.

The Chinese maker is aligning strategy with the US market, and boards should read what that implies about supply, risk, and capital.

A 16 June 2026 partnership brings Beltone Asset Management funds onto Telda, shifting access in Egypt from paperwork to app.

Big IPO, bigger options debut: what it means for investors, risk teams, and anyone benchmarking market appetite.

SpaceX exercised its option for Cursor in an all-stock deal worth $60 billion, reshaping AI dealmaking expectations.

The valuation jump of $1T in a single day changes the reference point for risk capital and public-market comps.